_id
6919e3e43c536f8df2318058
Ticker
ABDX.LSE
Name
Abingdon Health Plc
Exchange
LSE
Address
York Biotech Campus, York, United Kingdom, YO41 1LZ
Country
UK
Sector
Healthcare
Industry
Diagnostics & Research
Currency
GBX
Website
https://www.abingdonhealth.com
Description
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Last Close
64000
Volume
2516
Current Price
6.6
Change
4.49999999999999
Last Updated
2025-12-29T14:56:19.765Z
Image
https://logo.clearbit.com/www.abingdonhealth.com
Ipo Date
-
Market Cap
16068649
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
5335000
Cost Of Revenue
3124000
Gross Profit
2211000
Operating Expenses
3729000
Operating Income
-1518000
Interest Expense
47000
Pretax Income
-863000
Net Income
-894000
Eps
-0.0023779907666023263
Dividends Per Share
-
Shares Outstanding
251072642
Income Tax Expense
31000
EBITDA
-475000
Operating Margin
-28.45360824742268
Total Other Income Expense Net
655000
Cash
1918000
Short Term Investments
-
Receivables
2686000
Inventories
526000
Total Current Assets
5130000
Property Plant Equipment
1044000
Total Assets
9313000
Payables
765000
Short Term Debt
261000
Long Term Debt
652000
Total Liabilities
4013000
Equity
5300000
Bs_currency_symbol
GBP
Depreciation
341000
Change In Working Capital
-796000
Cash From Operations
-959000
Capital Expenditures
321000
Cash From Investing
-338000
Cash From Financing
-460000
Net Change In Cash
-1753000
Cf_currency_symbol
-
PE
-
PB
468.1612033584906
ROE
-16.867924528301888
ROA
-9.599484591431333
FCF
-1280000
Fcf Percent
-0.23992502343017807
Piotroski FScore
0
Health Score
22
Deep Value Investing Score
3
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
5335000
Quarters > 0 > income Statement > cost Of Revenue
3124000
Quarters > 0 > income Statement > gross Profit
2211000
Quarters > 0 > income Statement > operating Expenses
3729000
Quarters > 0 > income Statement > operating Income
-1518000
Quarters > 0 > income Statement > interest Expense
47000
Quarters > 0 > income Statement > pretax Income
-863000
Quarters > 0 > income Statement > net Income
-894000
Quarters > 0 > income Statement > eps
-0.0023779907666023263
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
375947633
Quarters > 0 > income Statement > income Tax Expense
31000
Quarters > 0 > income Statement > EBITDA
-475000
Quarters > 0 > income Statement > operating Margin
-28.45360824742268
Quarters > 0 > income Statement > total Other Income Expense Net
655000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1918000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2686000
Quarters > 0 > balance Sheet > inventories
526000
Quarters > 0 > balance Sheet > total Current Assets
5130000
Quarters > 0 > balance Sheet > property Plant Equipment
1044000
Quarters > 0 > balance Sheet > total Assets
9313000
Quarters > 0 > balance Sheet > payables
765000
Quarters > 0 > balance Sheet > short Term Debt
261000
Quarters > 0 > balance Sheet > long Term Debt
652000
Quarters > 0 > balance Sheet > total Liabilities
4013000
Quarters > 0 > balance Sheet > equity
5300000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-894000
Quarters > 0 > cash Flow > depreciation
341000
Quarters > 0 > cash Flow > change In Working Capital
-796000
Quarters > 0 > cash Flow > cash From Operations
-959000
Quarters > 0 > cash Flow > capital Expenditures
321000
Quarters > 0 > cash Flow > cash From Investing
-338000
Quarters > 0 > cash Flow > cash From Financing
-460000
Quarters > 0 > cash Flow > net Change In Cash
-1753000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0023779907666023263
Quarters > 0 > ratios > PB
468.1612033584906
Quarters > 0 > ratios > ROE
-16.867924528301888
Quarters > 0 > ratios > ROA
-9.599484591431333
Quarters > 0 > ratios > FCF
-1280000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.23992502343017807
Quarters > 0 > health Score
22
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
3094000
Quarters > 1 > income Statement > cost Of Revenue
2177000
Quarters > 1 > income Statement > gross Profit
917000
Quarters > 1 > income Statement > operating Expenses
3276000
Quarters > 1 > income Statement > operating Income
-2359000
Quarters > 1 > income Statement > interest Expense
40000
Quarters > 1 > income Statement > pretax Income
-2633000
Quarters > 1 > income Statement > net Income
-2521000
Quarters > 1 > income Statement > eps
-0.007108609131342007
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
354640402
Quarters > 1 > income Statement > income Tax Expense
-112000
Quarters > 1 > income Statement > EBITDA
-2326000
Quarters > 1 > income Statement > operating Margin
-76.2443438914027
Quarters > 1 > income Statement > total Other Income Expense Net
-274000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
3671000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2065000
Quarters > 1 > balance Sheet > inventories
444000
Quarters > 1 > balance Sheet > total Current Assets
6180000
Quarters > 1 > balance Sheet > property Plant Equipment
798000
Quarters > 1 > balance Sheet > total Assets
9822000
Quarters > 1 > balance Sheet > payables
2304000
Quarters > 1 > balance Sheet > short Term Debt
246000
Quarters > 1 > balance Sheet > long Term Debt
741000
Quarters > 1 > balance Sheet > total Liabilities
3401000
Quarters > 1 > balance Sheet > equity
6421000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-2521000
Quarters > 1 > cash Flow > depreciation
267000
Quarters > 1 > cash Flow > change In Working Capital
254000
Quarters > 1 > cash Flow > cash From Operations
-2146000
Quarters > 1 > cash Flow > capital Expenditures
6000
Quarters > 1 > cash Flow > cash From Investing
-1189000
Quarters > 1 > cash Flow > cash From Financing
5566000
Quarters > 1 > cash Flow > net Change In Cash
2231000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.007108609131342007
Quarters > 1 > ratios > PB
364.52681096402426
Quarters > 1 > ratios > ROE
-39.26179722784613
Quarters > 1 > ratios > ROA
-25.66687029118306
Quarters > 1 > ratios > FCF
-2152000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.6955397543632837
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
3725000
Quarters > 2 > income Statement > cost Of Revenue
1465000
Quarters > 2 > income Statement > gross Profit
2260000
Quarters > 2 > income Statement > operating Expenses
2380000
Quarters > 2 > income Statement > operating Income
-120000
Quarters > 2 > income Statement > interest Expense
23000
Quarters > 2 > income Statement > pretax Income
-179000
Quarters > 2 > income Statement > net Income
-66000
Quarters > 2 > income Statement > eps
-0.0002135689864747861
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
309033634
Quarters > 2 > income Statement > income Tax Expense
-113000
Quarters > 2 > income Statement > EBITDA
266000
Quarters > 2 > income Statement > operating Margin
-3.2214765100671143
Quarters > 2 > income Statement > total Other Income Expense Net
-59000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1440000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1083000
Quarters > 2 > balance Sheet > inventories
441000
Quarters > 2 > balance Sheet > total Current Assets
3548000
Quarters > 2 > balance Sheet > property Plant Equipment
997000
Quarters > 2 > balance Sheet > total Assets
5090000
Quarters > 2 > balance Sheet > payables
605000
Quarters > 2 > balance Sheet > short Term Debt
240000
Quarters > 2 > balance Sheet > long Term Debt
722000
Quarters > 2 > balance Sheet > total Liabilities
2841000
Quarters > 2 > balance Sheet > equity
2249000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-66000
Quarters > 2 > cash Flow > depreciation
141000
Quarters > 2 > cash Flow > change In Working Capital
-475000
Quarters > 2 > cash Flow > cash From Operations
-455000
Quarters > 2 > cash Flow > capital Expenditures
17000
Quarters > 2 > cash Flow > cash From Investing
-32000
Quarters > 2 > cash Flow > cash From Financing
-71000
Quarters > 2 > cash Flow > net Change In Cash
-558000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0002135689864747861
Quarters > 2 > ratios > PB
906.90172716763
Quarters > 2 > ratios > ROE
-2.9346376167185415
Quarters > 2 > ratios > ROA
-1.2966601178781925
Quarters > 2 > ratios > FCF
-472000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.12671140939597317
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
2410000
Quarters > 3 > income Statement > cost Of Revenue
1132000
Quarters > 3 > income Statement > gross Profit
1278000
Quarters > 3 > income Statement > operating Expenses
2672000
Quarters > 3 > income Statement > operating Income
-1253000
Quarters > 3 > income Statement > interest Expense
34000
Quarters > 3 > income Statement > pretax Income
-1220000
Quarters > 3 > income Statement > net Income
-1205000
Quarters > 3 > income Statement > eps
-0.003929334265612725
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
306667725
Quarters > 3 > income Statement > income Tax Expense
-15000
Quarters > 3 > income Statement > EBITDA
-901000
Quarters > 3 > income Statement > operating Margin
-51.991701244813285
Quarters > 3 > income Statement > total Other Income Expense Net
33000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1998000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
999000
Quarters > 3 > balance Sheet > inventories
411000
Quarters > 3 > balance Sheet > total Current Assets
3754000
Quarters > 3 > balance Sheet > property Plant Equipment
977000
Quarters > 3 > balance Sheet > total Assets
4822000
Quarters > 3 > balance Sheet > payables
2000000
Quarters > 3 > balance Sheet > short Term Debt
194000
Quarters > 3 > balance Sheet > long Term Debt
721000
Quarters > 3 > balance Sheet > total Liabilities
3008000
Quarters > 3 > balance Sheet > equity
1814000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-1205000
Quarters > 3 > cash Flow > depreciation
142500
Quarters > 3 > cash Flow > change In Working Capital
393000
Quarters > 3 > cash Flow > cash From Operations
-1173000
Quarters > 3 > cash Flow > capital Expenditures
18000
Quarters > 3 > cash Flow > cash From Investing
-22000
Quarters > 3 > cash Flow > cash From Financing
-43000
Quarters > 3 > cash Flow > net Change In Cash
-1238000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.003929334265612725
Quarters > 3 > ratios > PB
1115.7701130099229
Quarters > 3 > ratios > ROE
-66.42778390297684
Quarters > 3 > ratios > ROA
-24.989630858564908
Quarters > 3 > ratios > FCF
-1191000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.4941908713692946
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
8429000
Annuals > 0 > income Statement > cost Of Revenue
5301000
Annuals > 0 > income Statement > gross Profit
3128000
Annuals > 0 > income Statement > operating Expenses
7153000
Annuals > 0 > income Statement > operating Income
-4025000
Annuals > 0 > income Statement > interest Expense
75000
Annuals > 0 > income Statement > pretax Income
-3805000
Annuals > 0 > income Statement > net Income
-3415000
Annuals > 0 > income Statement > eps
-0.009313868219684964
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
366657539
Annuals > 0 > income Statement > income Tax Expense
-390000
Annuals > 0 > income Statement > EBITDA
-3122000
Annuals > 0 > income Statement > operating Margin
-47.75180923003915
Annuals > 0 > income Statement > total Other Income Expense Net
220000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
1918000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2686000
Annuals > 0 > balance Sheet > inventories
526000
Annuals > 0 > balance Sheet > total Current Assets
5130000
Annuals > 0 > balance Sheet > property Plant Equipment
1044000
Annuals > 0 > balance Sheet > total Assets
9313000
Annuals > 0 > balance Sheet > payables
765000
Annuals > 0 > balance Sheet > short Term Debt
261000
Annuals > 0 > balance Sheet > long Term Debt
652000
Annuals > 0 > balance Sheet > total Liabilities
4013000
Annuals > 0 > balance Sheet > equity
5300000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-3415000
Annuals > 0 > cash Flow > depreciation
608000
Annuals > 0 > cash Flow > change In Working Capital
-542000
Annuals > 0 > cash Flow > cash From Operations
-3182000
Annuals > 0 > cash Flow > capital Expenditures
327000
Annuals > 0 > cash Flow > cash From Investing
-1427000
Annuals > 0 > cash Flow > cash From Financing
5083000
Annuals > 0 > cash Flow > net Change In Cash
478000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.009313868219684964
Annuals > 0 > ratios > PB
433.52757243347173
Annuals > 0 > ratios > ROE
-64.43396226415095
Annuals > 0 > ratios > ROA
-36.669172124986574
Annuals > 0 > ratios > FCF
-3509000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.4163008660576581
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
6135000
Annuals > 1 > income Statement > cost Of Revenue
2456000
Annuals > 1 > income Statement > gross Profit
3679000
Annuals > 1 > income Statement > operating Expenses
5052000
Annuals > 1 > income Statement > operating Income
-1373000
Annuals > 1 > income Statement > interest Expense
57000
Annuals > 1 > income Statement > pretax Income
-1399000
Annuals > 1 > income Statement > net Income
-1271000
Annuals > 1 > income Statement > eps
-0.004170874404030943
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
304732264
Annuals > 1 > income Statement > income Tax Expense
-128000
Annuals > 1 > income Statement > EBITDA
-916000
Annuals > 1 > income Statement > operating Margin
-22.379788101059496
Annuals > 1 > income Statement > total Other Income Expense Net
-26000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1440000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1083000
Annuals > 1 > balance Sheet > inventories
441000
Annuals > 1 > balance Sheet > total Current Assets
3548000
Annuals > 1 > balance Sheet > property Plant Equipment
997000
Annuals > 1 > balance Sheet > total Assets
5090000
Annuals > 1 > balance Sheet > payables
605000
Annuals > 1 > balance Sheet > short Term Debt
120000
Annuals > 1 > balance Sheet > long Term Debt
722000
Annuals > 1 > balance Sheet > total Liabilities
2841000
Annuals > 1 > balance Sheet > equity
2249000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-1271000
Annuals > 1 > cash Flow > depreciation
426000
Annuals > 1 > cash Flow > change In Working Capital
-744000
Annuals > 1 > cash Flow > cash From Operations
-1659000
Annuals > 1 > cash Flow > capital Expenditures
41000
Annuals > 1 > cash Flow > cash From Investing
-23000
Annuals > 1 > cash Flow > cash From Financing
-114000
Annuals > 1 > cash Flow > net Change In Cash
-1796000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.004170874404030943
Annuals > 1 > ratios > PB
849.104137653357
Annuals > 1 > ratios > ROE
-56.51400622498889
Annuals > 1 > ratios > ROA
-24.970530451866406
Annuals > 1 > ratios > FCF
-1700000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.27709861450692747
Annuals > 1 > health Score
17
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
4045000
Annuals > 2 > income Statement > cost Of Revenue
2643000
Annuals > 2 > income Statement > gross Profit
1402000
Annuals > 2 > income Statement > operating Expenses
5248000
Annuals > 2 > income Statement > operating Income
-3846000
Annuals > 2 > income Statement > interest Expense
75000
Annuals > 2 > income Statement > pretax Income
-3574000
Annuals > 2 > income Statement > net Income
-3469000
Annuals > 2 > income Statement > eps
-0.011343258242860303
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
305820420
Annuals > 2 > income Statement > income Tax Expense
-105000
Annuals > 2 > income Statement > EBITDA
-2811000
Annuals > 2 > income Statement > operating Margin
-95.08034610630408
Annuals > 2 > income Statement > total Other Income Expense Net
14000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
3236000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1098000
Annuals > 2 > balance Sheet > inventories
329000
Annuals > 2 > balance Sheet > total Current Assets
4762000
Annuals > 2 > balance Sheet > property Plant Equipment
1257000
Annuals > 2 > balance Sheet > total Assets
6061000
Annuals > 2 > balance Sheet > payables
1111000
Annuals > 2 > balance Sheet > short Term Debt
174000
Annuals > 2 > balance Sheet > long Term Debt
708000
Annuals > 2 > balance Sheet > total Liabilities
3052000
Annuals > 2 > balance Sheet > equity
3009000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-3451000
Annuals > 2 > cash Flow > depreciation
673000
Annuals > 2 > cash Flow > change In Working Capital
3672000
Annuals > 2 > cash Flow > cash From Operations
1002000
Annuals > 2 > cash Flow > capital Expenditures
157000
Annuals > 2 > cash Flow > cash From Investing
-156000
Annuals > 2 > cash Flow > cash From Financing
-7000
Annuals > 2 > cash Flow > net Change In Cash
839000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.011343258242860303
Annuals > 2 > ratios > PB
636.9073592462612
Annuals > 2 > ratios > ROE
-115.28747092057161
Annuals > 2 > ratios > ROA
-57.23477973931694
Annuals > 2 > ratios > FCF
845000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.2088998763906057
Annuals > 2 > health Score
36
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
2835000
Annuals > 3 > income Statement > cost Of Revenue
8064000
Annuals > 3 > income Statement > gross Profit
-5229000
Annuals > 3 > income Statement > operating Expenses
6876000
Annuals > 3 > income Statement > operating Income
-12105000
Annuals > 3 > income Statement > interest Expense
69000
Annuals > 3 > income Statement > pretax Income
-21685000
Annuals > 3 > income Statement > net Income
-21262000
Annuals > 3 > income Statement > eps
-0.07290929176767134
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
291622638
Annuals > 3 > income Statement > income Tax Expense
-331000
Annuals > 3 > income Statement > EBITDA
-19979000
Annuals > 3 > income Statement > operating Margin
-426.984126984127
Annuals > 3 > income Statement > total Other Income Expense Net
-65000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
2397000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
8338000
Annuals > 3 > balance Sheet > inventories
534000
Annuals > 3 > balance Sheet > total Current Assets
10958000
Annuals > 3 > balance Sheet > property Plant Equipment
1777000
Annuals > 3 > balance Sheet > total Assets
12771000
Annuals > 3 > balance Sheet > payables
2471000
Annuals > 3 > balance Sheet > short Term Debt
265000
Annuals > 3 > balance Sheet > long Term Debt
435000
Annuals > 3 > balance Sheet > total Liabilities
6339000
Annuals > 3 > balance Sheet > equity
6432000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-21262000
Annuals > 3 > cash Flow > depreciation
1637000
Annuals > 3 > cash Flow > change In Working Capital
-5358000
Annuals > 3 > cash Flow > cash From Operations
-7735000
Annuals > 3 > cash Flow > capital Expenditures
760000
Annuals > 3 > cash Flow > cash From Investing
-760000
Annuals > 3 > cash Flow > cash From Financing
5915000
Annuals > 3 > cash Flow > net Change In Cash
-2580000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.07290929176767134
Annuals > 3 > ratios > PB
284.1235110837687
Annuals > 3 > ratios > ROE
-330.56592039800995
Annuals > 3 > ratios > ROA
-166.48657113773393
Annuals > 3 > ratios > FCF
-8495000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-2.99647266313933
Annuals > 3 > health Score
23
Valuation > metrics > PE
-0.0023779907666023263
Valuation > metrics > PB
468.1612033584906
Valuation > final Score
20
Valuation > verdict
15505.4% Overvalued
Profitability > metrics > ROE
-16.867924528301888
Profitability > metrics > ROA
-17.42690058479532
Profitability > metrics > Net Margin
-0.167572633552015
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7571698113207547
Risk > metrics > Interest Coverage
-32.297872340425535
Risk > final Score
-81
Risk > verdict
High
Liquidity > metrics > Current Ratio
5
Liquidity > metrics > Quick Ratio
4.487329434697855
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-188
Prev Risks > 1
9
Prev Risks > 2
-117
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
93
Updated At
2026-01-20T22:59:38.916Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-03-24
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.01
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.01
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-12-31
Earnings History > 2 > report Date
2023-03-31
Earnings History > 2 > date
2022-12-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
-0.02
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-09-30
Earnings History > 3 > report Date
2022-11-24
Earnings History > 3 > date
2022-09-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.13
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-12-31
Earnings History > 4 > report Date
2022-03-29
Earnings History > 4 > date
2021-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.02
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-09-30
Earnings History > 5 > report Date
2021-11-18
Earnings History > 5 > date
2021-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.07
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.07
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-12-31
Earnings History > 6 > report Date
2021-03-09
Earnings History > 6 > date
2020-12-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.01
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-09-30
Earnings History > 7 > report Date
2020-12-15
Earnings History > 7 > date
2020-09-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-0.04
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.04
Earnings History > 7 > surprise Percent
-
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAbingdon Health on FTSE AIM Shares as (LSE:ABDX) Activity Draws Market Focus - Kalkine Media
1/15/2026
Abingdon Health on FTSE AIM Shares as (LSE:ABDX) Activity Draws Market Focus Kalkine Media
Read more →Abingdon Health plc (LSE:ABDX) Positioned Within FTSE AIM Indices and Diagnostics Sector Kalkine Media
Read more →Showing 2 of 4
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Abingdon Health Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.